APA (7th ed.) Citation

T, S., AA, G., CT, S., SA, T. D., JSF, C., L, D., . . . JR, U. (2025). Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 28, 15688. https://doi.org/10.3389/jpps.2025.15688

Chicago Style (17th ed.) Citation

T, Shafaati, et al. "Pharmacological Increases in Circulating Ketones Fail to Alleviate the Hypertrophic Cardiomyopathy Present in the Tafazzin Knockdown Mouse Model of Barth Syndrome." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques 28 (2025): 15688. https://doi.org/10.3389/jpps.2025.15688.

MLA (9th ed.) Citation

T, Shafaati, et al. "Pharmacological Increases in Circulating Ketones Fail to Alleviate the Hypertrophic Cardiomyopathy Present in the Tafazzin Knockdown Mouse Model of Barth Syndrome." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, vol. 28, 2025, p. 15688, https://doi.org/10.3389/jpps.2025.15688.